Exposure with response prevention treatment for obsessive-compulsive disorder

Clinical Obsessive-Compulsive Disorders in Adults and Children

Volumn , Issue , 2011, Pages 102-121

  Neziroglu, Fugen ^a   Forhman, Beth ^b   Khemlani Patel, Sony ^c  

^a HOFSTRA UNIVERSITY   (United States)

^b ADELPHI UNIVERSITY   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926104048     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511973796.009     Document Type: Chapter

References (160)

1. Abel J (1993). Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder. Behav Res Ther3: 463-478.
2. Abramowitz JS (1997). Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: A quantitative review of the controlled treatment literature. J Consult Clin Psychol65: 44-52.
3. Abramowitz JS, Franklin ME, Kozak MJ, Street GP, Foa EB (2000). The effects of pretreatment depression on cognitive-behavioral treatment outcome in OCD clinic patients. Behav Ther31: 517-528.
4. Abramowitz JS, Foa EB, Franklin ME (2003). Exposure and ritual prevention for obsessive-compulsive disorder: Effectiveness of intensive versus twice-weekly treatment sessions. J Consult Clin Psychol71: 394-398.
5. Abramowitz J, Taylor S, McKay D (2005a). Potentials and limitations of cognitive treatments for obsessive-compulsive disorder. Cogn Behav Ther34: 140-147.
6. Abramowitz JS, Whiteside SP, Deacon BJ (2005b). The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther36: 55-63.
7. Abramowitz JS, Taylor S, McKay D (eds.) (2008). Clinical Handbook of Obsessive-Compulsive Disorder and Related Problems. Baltimore, MD: Johns Hopkins University Press.
8. Amir N, Freshman MS, Foa EB (2000). Family accommodation and rejection in relatives of OCD patients. J Anxiety Disord14: 209-217.
9. Antony MM, Downie F, Swinson RP (1998). Diagnostic issues and epidemiology in obsessive-compulsive disorder. In Swinson RP Antony MM, Rachman S, Richter RA (eds.) Obsessive Compulsive Disorder: Theory, Research and Treatment(pp. 3-32). New York: Guilford Press.
10. Azrin NH, Nunn RG (1973). Habit reversal: a method of eliminating nervous habits and tics. Behav Res Ther11: 619-628.
11. Bagley A, Abramowitz C, Kosson D (2009). Vocal affect recognition and psychopathy: converging findings across traditional and cluster analytic approaches to assessing the construct. J Abnorm Psychol118: 388-398.
12. Baer L, Minichiello WW (1990). Behavior therapy for obsessive compulsive disorder. In Jenike MA, Baer L, Minichiello WE (eds.) Obsessive Compulsive Disorders: Theory and Management(pp. 203-232). Chicago, IL: Year Book Medical.
13. Baum M (1965). An automated apparatus for the avoidance training of rats. Psychol Rep16: 1205-1211.
14. Baum M (1969a). Extinction of an avoidance response following a period of response prevention in the avoidance apparatus. Psychol Rep18: 59-64.
15. Baum M (1969b). Paradoxical effect of alcohol on the resistance to extinction of an avoidance response in rats. J Compr Physiol Psychol69: 238-240.
16. Baum M (1970). Effect of alcohol on the acquisition and resistance to extinction of avoidance responses in rats. Psychol Rep26: 759-765.
17. Baxter LR, Schwartz JM, Bergmann KS, et al. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive compulsive disorder. Arch Gen Psychiatry49: 681-689.
18. Bejerot S, von Knorring L, Ekselius L (2000). Personality traits and smoking in patients with obsessive-compulsive disorder. Eur Psychiatry15: 395-401.
19. Bienvenu O, Samuels J, Riddle M, et al. (2000). The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biol Psychiatry48: 287-293.
20. Boersma K, den Hengst S, Dekker J, Emmelkamp PMG (1976). Exposure and response prevention in the natural environment: A comparison with obsessive-compulsive patients. Behav Res Ther14: 19-24.
21. Bolton D, Luckie M, Steinberg D (1995). Obsessive compulsive disorder treated in adolescence: 14 long term case histories. Clin Child Psychol Psychiatry1: 409-430.
22. Boulougouris JC, Bassiakos L (1973). Prolonged flooding in cases with obsessive-compulsive neurosis. Behav Res Ther11: 227-231.
23. Brakoulias V, Starcevic V (2008). Symptom subtypes of obsessive compulsive disorder: Are they relevant for treatment? Aust N Z J Psychiatry42: 651-661.
24. Calamari JE, Wiegartz PS, Janeck AS (1999). Obsessive compulsive disorder subgroups: a symptom-based clustering approach. Behav Res Ther37: 113-125.
25. Catts S, McConaghy N (1975). Ritual prevention in the treatment of obsessive compulsive neurosis. Aust N Z J Psychiatry9: 37-41.
26. Cath DC, Spinhoven PH, van der Wetering BJM, et al. (2000). The relationship between types and severity of repetitive behaviors in Gilles de la Tourette’s syndrome and obsessive-compulsive disorder. J Clin Psychiatry61: 505-513.
27. Cath DC, Spinhoven PH, Hoogduin CAL, et al. (2001). Repetitive behaviors in Tourette’s syndrome and obsessive-compulsive disorder with and without tics: What are the differences? Psychiatry Res101: 171-185.
28. Charash M, McKay D (2002). Attention bias for disgust. J Anxiety Disord16: 529-541.
29. Chen EY, Matthews L, Allen C, Kuo JR, Linehan MM (2008). Dialectical behavior therapy for clients with binge-eating disorder or bulimia nervosa and borderline personality disorder. Int J Eating Disord41: 505-512.
30. Christenson G, Pyle R, Mitchell J (1991). Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry52: 415-417.
31. Cisler JM, Reardon JM, Williams NL, Lohr JM (2007). Anxiety sensitivity and disgust sensitivity interact to predict contamination fears. Pers Individ Dif42: 935-946.
32. Dalrymple KL, Herbert JD (2007). Acceptance and commitment therapy for generalized social anxiety disorder: A pilot study. Behav Modif31: 543-568.
33. Deacon B, Olatunji BO (2007). Specificity of disgust sensitivity in the prediction of behavioral avoidance in contamination fear. Behav Res Ther45: 2110-2120.
34. Dimeff L, Rizvi SL, Brown M, Linehan MM (2000). Dialectical behavior therapy for substance abuse: A pilot application to methamphetamine dependent women with borderline personality disorder. Cogn Behav Pract7: 457-468.
35. Dollard J, Miller E (1950). Personality and Psychotherapy: An Analysis in Terms of Learning, Thinking and Culture. New York: McGraw-Hill.
36. Emmelkamp PME, Beens H (1991). Cognitive therapy with obsessive compulsive disorder: a comparative evaluation. Behav Res Ther29: 293-300.
37. Emmelkamp PME, Visser S, Hoekstra R (1988). Cognitive therapy versus exposure in vivo in the treatment of obsessive compulsives. Cogn Ther Res12: 103-114.
38. Eifert G, Heffner M (2003). The effects of acceptance versus control contexts on avoidance of panic-related symptoms. J Behav Ther Exp Psychiatry34: 293-312.
39. Eisen J, Phillips K, Baer L, et al. (1998). The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry155: 102-108.
40. Fallon BA, Javitch JA, Hollander E, Liebowitz MR (1992). Hypochondriasis and obsessive compulsive disorder: overlaps in diagnosis and treatment. J Clin Psychiatry52: 457-460.
41. Foa EB (1979). Failure in treating obsessive-compulsives. Behav Res Ther17: 169-176.
42. Foa E, Goldstein A (1978). Continuous exposure and complete response prevention in the treatment of obsessive compulsive neurosis. Behav Ther9: 821-829.
43. Foa EB, Kozak J (1996). Psychological treatment for obsessive compulsive disorder. In Mavissakalian MR, Prien RF (eds.) Long-term Treatments of Anxiety Disorders(pp. 285-309). Washington DC: American Psychiatric Press.
44. Foa EB, Grayson JB, Steketee GS, et al. (1983). Success and failure in the behavioral treatment of obsessive-compulsives. J Consult Clin Psychol51: 287-297.
45. Foa E, Franklin M, Kozak M (1998). Psychosocial treatment for obsessive compulsive disorder: literature review. In Swinson RP Antony MM, Rachman S, Richter RA (eds.) Obsessive Compulsive Disorder: Theory, Research, and Treatment(pp. 258-276). New York: Guilford Press.
46. Foa EB, Huppert JD, Leiberg S, et al. (2002). The obsessive compulsive inventory: development and validation of a short version. Psychol Assess14: 485-496.
47. Foa EB Liebowitz MR, Kozak J, et al. (2005). Randomized placebo-controlled trial of ERP, clomipramine, and their combination in the treatment of OCD Am J Psychiatry162: 151-161.
48. Folette VM, Smith AA (2005). Exposure therapy. In Freeman A, Felgoise SH, Nezu CM, Nezu AM, Reinecke MA (eds.) Encyclopedia of Cognitive Behavior Therapy(pp.185-187). New York: Springer.
49. George MS, Trimble MR, Ring HA, Sallee FR, Robertson MM (1993). Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette’s syndrome. Am J Psychiatry150: 93-97.
50. Goodman WK, Price LH, Rasmussen SA, et al. (1989). The Yale-Brown Obsessive Compulsive Scale: II Validity. Arch Gen Psychiatry46: 1012-1016.
51. Hachman A, McLean C (1975). A comparison of flooding and thought stopping in the treatment of obsessional neurosis. Behav Res Ther34: 47-51.
52. Hasler G, LaSalle-Ricci VH, Ronquillo JG, et al. (2005). Obsessive compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity. Psychiatry Res135: 121.
53. Hayes SC, Pierson H (2005). Acceptance and commitment therapy. In Freeman A, Felgoise SH, Nezu CM, Nezu AM, Reinecke MA (eds.) Encyclopedia of Cognitive Behavior Therapy(pp.1-4). New York: Springer.
54. Hayes SC, Barnes-Holmes D, Roche B (eds.) (2001). Relational Frame Theory: A Post-Skinnerian Account of Human Language and Cognition. New York: Kluwer Academic.
55. Hayes S, Luoma J, Bond F, Masuda A, Lillis J (2006). Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther44: 1-25.
56. Hembree EA, Riggs DS, Kozak MJ, Franklin ME, Foa EB (2003). Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder. CNS Spectr8: 363-371.
57. Hodgson R, Rachman S, Marks I (1972). The treatment of chronic obsessive-compulsive neurosis: Follow-up and further findings. Behav Res Ther10: 181-189.
58. Hollander E (1993). Obsessive-compulsive spectrum disorders: an overview. Psychiatr Ann23: 355-358.
59. Hollander E, Cohen L (1996). Psychobiology and psychopharmacology of compulsive spectrum disorders. In Oldham JM, Hollander E, Skodol AE (eds.) Impulsivity and Compulsivity(pp. 143-166). Washington, DC: American Psychiatric Press.
60. Hollander E, Wong C (1995). Obsessive compulsive spectrum disorders. J Clin Psychiatry56: 3-6.
61. Hollander E, Cohen L, Simeon D (1993). Body dysmorphic disorder. Psychiatr Ann23: 359-364.
62. Holzer JC, Goodman WK, McDougle CJ, et al. (1994). Obsessive-compulsive disorder with and without a chronic tic disorder: a comparison of symptoms in 70 patients. Br J Psychiatry164: 469-473.
63. Hoogduin CAL, Duivenvoorden HJ (1988). A decision model in the treatment of obsessive compulsive neuroses. Br J Psychiatry152: 515-521.
64. Huppert JD, Foa EB (2005). Severe OCD. In Freeman A, Felgoise SH, Nezu CM, Nezu AM, Reinecke MA (eds.) Encyclopedia of Cognitive Behavior Therapy(pp. 347-349). New York: Springer.
65. Husted DS, Shapira NA, Goodman WK (2006). The neurocircuitry of obsessive-compulsive disorder and disgust. Prog Neuropsychopharmacol Biol Psychiatry30: 389-399.
66. Jaspers K (1913). General Psychopathology. Berlin: Springer.
67. Keijsers GP, Hoogduin CA, Schaap CP (1994). Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder. Br J Psychiatry165: 781-786.
68. Kushner MG, Won KS, Donahue C, et al. (2007). d-Cycloserine augmented exposure therapy for obsessive compulsive disorder. Biol Psychiatry62: 835-838.
69. Kishore R, Samar R, Reddy J, Chandrasekhar CR, Thennarasu K (2004). Clinical characteristics and treatment response in poor and good insight obsessive compulsive disorder. Eur Psychiatry19: 202-208.
70. Kirk J (1983). Behavioural treatment of obsessional-compulsive patients in routine clinical practice. Behav Res Ther21: 57-62.
71. Kozak M, Foa E (1994). Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther32: 343-353.
72. Lawrence NS, An KS, Mataix-Cols D, et al. (2007). Neural responses to facial expressions of disgust but not fear are modulated by washing symptoms in OCD. Biol Psychiatry61: 1072-1080.
73. Leckman JF, Grice DE, Boardman J, et al. (1997). Symptoms of obsessive compulsive disorder. Am J Psychiatry154: 911-917.
74. Lee HJ, Kwon SM (2003). Two different types of obsession: autogenous obsessions and reactive obsessions. Behav Res Ther41: 11-29.
75. Lee HJ, Telch MJ (2005). Autogenous/reactive obsessions and their relationship with OCD symptoms and schizotypal personality features. J Anxiety Disord19: 793-805.
76. Lee HJ, Kim ZS, Kwon SM (2005a). Thought disorder in patients with obsessive-compulsive disorder. J Clin Psychol61: 401-413.
77. Lee H, Kwon S, Kwon J, Telch M (2005b). Testing the autogenous-reactive model of obsessions. Depress Anxiety21: 118-129.
78. Lindsay M, Crino R, Andrews G (1997). Controlled trial of exposure and response prevention in obsessive compulsive disorder. Br J Psychiatry171: 135-139.
79. Maier N (1949). Frustration: The Study of Behavior Without a Goal. New York: McGraw-Hill.
80. Marks IM, Hodgson R, Rachman S (1975). Treatment of chronic obsessive-compulsive neurosis by in vivo exposure. Br J Psychiatry127: 349-364.
81. Marks IM, Stern RS, Mawson D, Cobb J, McDonald R (1980). Clomipramine and exposure for obsessive compulsive rituals. Br J Psychiatry136: 1-25.
82. Marks IM, Lelliott PT, Basoglu M, et al. (1988). Clomipramine, self-exposure, and therapist-aided exposure for obsessive-compulsive rituals. Br J Psychiatry152: 522-534.
83. Masellis M, Rector NA, Richter MA (2003). Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiatry48: 72-77.
84. Mataix-Cols D, Marks I, Greist J, Kobak K, Baer L (2002). Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: Results from a controlled trial. Psychother Psychosomat71: 255-262.
85. Mavissakalian M, Turner SM, Michelson L (1985). Future directions in the assessment and treatment of obsessive compulsive disorder. In Mavissakalian M, Turner SM, Michelson L (eds.) Obsessive-Compulsive Disorder: Psychological and Pharmacological Treatment(pp. 213-228). New York: Plenum Press.
86. Mawson D, Marks IM, Romm L (1982). Clomipramine and exposure for chronic obsessive compulsive disorders: two year follow-up and further findings. Br J Psychiatry140: 11-18.
87. McKay D (2006). Treating disgust reactions in contamination-based obsessive-compulsive disorder. J Behav Ther Exp Psychiatry37: 53-59.
88. McKay D, Neziroglu F (1996). Social skills training in a case of obsessive compulsive disorder with schizotypal personality disorder. J Behav Ther Exp Psychiatry27: 189-194.
89. McKay D, Neziroglu F (2009). Methodological issues in the obsessive compulsive spectrum. Psychiatry Res170: 61-65.
90. McKay D, Neziroglu F, Yaryura-Tobias JA (1997). Comparison of clinical characteristics in obsessive compulsive disorder and body dysmorphic disorder. J Anxiety Disord11: 447-454.
91. Meyer V (1966). Modification of expectations in cases with obsessional rituals. Behav Res Ther4: 273-280.
92. Miguel EC, Leckman JF, Rauch S, et al. (2005). Obsessive compulsive disorder phenotypes: Implications for genetic studies. Mol Psychiatry10: 258-275.
93. Mills HL, Stewart A, Barlow DH, Mills JR (1973). Compulsive rituals treated by response prevention: an experimental analysis. Arch Gen Psychiatry28: 524-529.
94. Mowrer H (1947). On the dual nature of learning: A reinterpretation of conditioning and problem solving. Harvard Educ Rev17: 102-148.
95. Neacsiu AD, Rizvi SL, Linehan MM (2010). Dialectical behavior therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behav Res Ther48: 832-839.
96. Neziroglu F, Khemlani-Patel S (2005). Overlap of body dysmorphic disorder and hypochondriasis with OCD. In Abramowitz JS, Houts AC (eds.) Concepts and Controversies in Obsessive-Compulsive Disorder(pp. 163-175). New York: Springer.
97. Neziroglu F, Neuman J (1990). Three approaches to the treatment of obsessions. Int J Cogn Ther4: 371-392.
98. Neziroglu F, Yaryura-Tobias JA (1993). Exposure, response prevention, and cognitive therapy in the treatment of body dysmorphic disorder. Behav Ther24, 431-438.
99. Neziroglu F, Steele J, Yaryura-Tobias JA (1990). Effect of behavior therapy on serotonin level in obsessive compulsive disorder. In Stefanis CN (ed.) Psychiatry: A World Perspective(pp. 707-710). New York: Elsevier.
100. Neziroglu F, McKay D, Yaryura-Tobias JA, Stevens K, Todaro J, (1999). The overvalues ideas scale: development, reliability and validity in obsessive-compulsive disorder. J Res Behav Ther37: 881-902.
101. Neziroglu F, McKay D, Yaryura-Tobias J (2000). Overlapping and distinctive features of hypochondriasis and obsessive-compulsive disorder. J Anxiety Disord14: 603-614.
102. Neziroglu F, Stevens K, McKay D, Yaryura-Tobias JA, (2001) Predictive validity of the overvalued ideas scale: outcome in obsessive-compulsive and body dysmorphic disorders. J Res Behav Ther39: 745-756.
103. Neziroglu F, Bubrick J, Yaryura-Tobias JA (2004). Overcoming Compulsive Hoarding. Oakland, CA: New Harbinger Press.
104. Neziroglu F, Henricksen J, Yaryura-Tobias J (2006). Psychotherapy of Obsessive-Compulsive Disorder and Spectrum: Established Facts and Advances 1995-5005. Psychiatr Clin N Am29: 585-604.
105. Neziroglu F, Weissman S, Yaryura-Tobias JA, Allen J (2010). Compulsive hoarders: how they are similar to individuals with obsessive compulsive disorder? J Behav Res Ther in press.
106. Obsessive Compulsive Cognitions Working Group (1997). Cognitive assessment of obsessive compulsive disorder. Behav Res Ther 35: 667-681.
107. Olatunji BO, Sawchuk CN, Lohr JM, de Jong PJ (2004). Disgust domains in the prediction of contamination fear. Behav Res Ther42: 93-104.
108. Olatunji BO, Lohr JM, Sawchuk CN, Tolin DF (2007). Multimodal assessment of disgust in contamination-related obsessive-compulsive disorder. Behav Res Ther45: 263-276.
109. O’Sullivan G, Noshirvani H, Marks I, et al. (1991). Six year follow up after exposure and clomipramine therapy for obsessive compulsive disorder. J Clin Psychiatry52: 150-155.
110. Perugi G, Giannotti D, Frare F, et al. (1997). Prevalence, phenomenology and co-morbidity of body dysmorphic disorder in a clinical population. Int J Psychiatr Clin Pract1: 77-82.
111. Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI (1993). Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry150: 302-308.
112. Phillips M, Marks I, Senior C, et al. (2000). A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychol Med30: 1037-1050.
113. Rabavilas AD, Boulougouris JC, Stefanis D (1976). Duration of flooding session in the treatment of obsessive compulsive patients. Behav Res Ther14: 349-355.
114. Rachman S, Hodgson R, Marks IM (1971). The treatment of chronic obsessive-compulsive neurosis. Behav Res Ther9: 237-247.
115. Rachman S, Marks I, Hodgson R (1973). The treatment of obsessive-compulsive neurotics by modeling and flooding in vivo. Behav Res Ther11: 463-471.
116. Rasmussen SA, Eisen JL (1992). The epidemiology and clinical features of obsessive-compulsive disorder. J Clin Psychiatry53: 4-10.
117. Rasmussen SA, Tsuang MT (1986). Clinical characteristics and family history in DSM-III obsessive compulsive disorder. Am J Psychiatry14: 317-322.
118. Rauch SL, Jenike MA, Alpert NM, et al. (1994). Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry51: 62-70.
119. Rauch SL, Baer L, Jenike MA (1996). Treatment resistant obsessive-compulsive disorder: practical strategies for management. In Pollack MH, Otto MW, Rosenbaum JF (eds.) Challenges in Psychiatric Treatment: Pharmacologic and Psychosocial Perspectives(pp. 201-218). New York: Guilford Press.
120. Rector NA, Richter MA, Bagby RM (2005). The impact of personality on symptom expression in obsessive compulsive disorder. J Nerv Ment Dis193: 231-236.
121. Salkovskis PM, Warwick HMC (2001). Meaning, misinterpretations and medicine: a cognitive-behavioral approach to understanding health anxiety and hypochondriasis. In Starcevic V, Lipsitt DR (eds.) Hypochondriasis: Modern Perspectives on an Ancient Malady(pp. 202-222). London: Oxford University Press.
122. Samuels J, Nestadt G, Bienvenu OJ, et al. (2000). Personality disorders and normal personality dimensions in obsessive compulsive disorder. Br J Psychiatry177: 457-462.
123. Saxena S, Maidment KM, Vapnik T, et al. (2002). Obsessive compulsive hoarding: symptom severity and response to multi-modal treatment. J Clin Psychiatry63: 21-27.
124. Saxena S, Gorbis E, O’Neill J, et al. (2009). Rapid effects of brief intensive cognitive behavioral therapy on brain glucose metabolism in obsessive compulsive disorder. Mol Psychiatry14: 197-205.
125. Sawchuk CN, Olatunji BO, de Jong PJ (2006). Disgust domains in the prediction of contamination fear: A comparison of Dutch and US samples. Anxiety Stress Coping19: 397-407.
126. Schienle A, Schafer A, Stark R, Walter B, Vaitl D (2005a). Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiol57: 69-77.
127. Schienle A, Schafer A, Stark R, Walter B, Vaitl D (2005b). Relationship between disgust sensitivity, trait anxiety and brain activity during disgust induction. Neuropsychobiology51: 86-92.
128. Schwartz JM, Stoessel PW, Baxter LR, Martin KM, Phelps M (1996). Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive compulsive disorder. Arch Gen Psychiatry53: 109-113.
129. Seishin SZ (2008). A review of the research focusing on the heterogeneity of obsessive compulsive disorder and its potential subtypes. Psychiatr Neurol Jap110: 161-174.
130. Shapira NA, Liu Y, He AG, et al. (2003). Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry54: 751-756.
131. Simpson HB, Liebowitz M, Foa EB, et al. (2004). Post-treatment effects of exposure therapy and clomipramine in obsessive compulsive disorder. Depress Anxiety19: 225-233.
132. Simpson HB, Zuckoff A, Page JR, Franklin ME, Foa EB (2008a). Adding motivational interviewing to exposure and ritual prevention for obsessive compulsive disorder. Cogn Behav Ther37: 38-49.
133. Simpson HB, Foa EB Liebowitz MR, et al. (2008b). A randomized, controlled trial of cognitive behavioral therapy for augmenting pharmacotherapy in obsessive compulsive disorder. Am J Psychiatry165: 621-630.
134. Solyom L, Sookman D (1977). A comparison of clomipramine hydrochloride (Anafranil) and behaviour therapy in the treatment of obsessive neurosis. J Int Med Res5: 49-61.
135. Sprengelmeyer R, Rausch M, Eysel UT, Przuntek H (1998). Neural structures associated with recognition of facial expressions of basic emotions. Proc Biological Science265: 1927-1931.
136. Stanley M, Cohen L (1999). Trichotillomania and obsessive-compulsive disorder. In Stein DJ, Christenson GA, Hollander E (eds.) Trichotillomania(pp. 225-261). Washington, DC: American Psychiatric Press.
137. Stanley M, Turner S, Borden J (1990). Schizotypal features in obsessive-compulsive disorder. Compr Psychiatry31: 511-518.
138. Starcevic V (2001). Clinical features and diagnosis of hypochondriasis. In Starcevic V, Lipsitt DR (eds.) Hypochondriasis: Modern Perspectives on an Ancient Malady(pp. 21-60). London: Oxford University Press.
139. Steingard R, Dillon-Stout D (1992). Tourette’s syndrome and obsessive compulsive disorder: clinical aspects. Psychiatr Clin N Am15: 849-960.
140. Steketee G, Frost R (2003). Compulsive hoarding: current status of the research. Clin Psychol Rev23: 905-927.
141. Steketee G, Frost R (2007). Treatments that Work: Compulsive Hoarding and Acquiring. Therapist Guide and Workbook. New York: Oxford University Press.
142. Steketee G, Van Noppen B (2003). Family approaches to treatment for obsessive compulsive disorder. Rev ABPAPAL25: 43-50.
143. Steketee G, Henninger N, Pollard C (2000). Predicting treatment outcomes for obsessive-compulsive disorder: effects of comorbidity. In Goodman WK, Rudorfer MV, Maser JD (eds.) Obsessive-Compulsive Disorder: Contemporary Issues in Treatment(pp. 257-274). Mahwah, NJ: Lawrence Erlbaum.
144. Storch EA, Merlo LJ, Bengston M, et al. (2007). d-Cycloserine does not enhance exposure and response prevention therapy in obsessive compulsive disorder. Int Clin Psychopharmacol22: 312.
145. Tolin DF, Woods CM, Abramowitz JS (2006). Disgust sensitivity and obsessive-compulsive symptoms in a non-clinical sample. J Behav Ther Exp Psychiatry37: 30-40.
146. Twohig MP, Hayes SC, Masuda A (2006). Increasing willingness to experience obsessions: acceptance and commitment therapy as a treatment for obsessive compulsive disorder. Behav Ther37: 3-13.
147. Tsao SD, McKay D (2004). Behavioral avoidance tests and disgust in contamination fears: distinctions from trait anxiety. Behav Res Ther42: 207-216.
148. Van Noppen B, Rasmussen S, Eisen J, McCartney L (1991). A multifamily group approach as an adjunct to treatment of obsessive-compulsive disorder. In Pato MT, Zohar J, (eds.) Current Treatments of Obsessive- Compulsive Disorder(pp. 115-134). Washington, DC: American Psychiatric Press.
149. Van Oppen P, de Haan E, Van Balkom AJLM, Spinhoven P (1995). Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther33: 379-390.
150. Van Oppen P, van Balkom A, de Haan E, van Dyck R (2005). Cognitive therapy and exposure in vivo alone. J Clin Psychiatry66: 1415-1422.
151. Verdellen CWJ, Keijsers GPJ, Cath DC, Hoogduin CAL (2004). Exposure with response prevention versus habit reversal in Tourette’s syndrome: A controlled study. Behav Res Ther42: 501-511.
152. Warwick H, Salkovskis P (1990). Hypochondriasis. Behav Res Ther28: 105-117.
153. Wernicke C (1906). Grundrisse der Psychiatrie (p. 416). [Fundamentals of Psychiatry.] Leipzig: Thieme.
154. Welner A, Reich T, Robbins E, Fishman E, Van Doren T (1976). Obsessive-compulsive neurosis: record, followup, and family studies. I. Inpatient record study. Compr Psychiatry17: 527-539.
155. Wetterneck CT, Woods DW (2006). An evaluation of the effectiveness of exposure and response prevention on repetitive behaviors associated with Tourette’s syndrome. J Appl Behav Anal39: 441-444.
156. Whittal ML, Thordarson DS, McLean PD (2005). Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention. Behav Res Ther43: 1559-1576.
157. Wilhelm S, Deckersbach T, Coffey BJ, et al. (2003). Habit reversal versus supportive psychotherapy for Tourrette’s disorder: A randomized controlled trial. Am J Psychiatry160: 1175-1177.
158. Wolpe J (1958). Psychotherapy by Reciprocal Inhibition. Stanford, CA: Stanford University Press.
159. Yaryura-Tobias JA, Neziroglu F (1997). Obsessive Compulsive Spectrum Disorders: Pathogenesis, Diagnosis and Treatment. Washington, DC: American Psychiatric Press.
160. Yurica CL, DiTomasso R (2001). Inventory of cognitive distortions: development and validation of a psychometric test for the measurement of cognitive distortions. Ph.D Thesis, Philadelphia College of Osteopathic Medicine.